150 related articles for article (PubMed ID: 3264311)
1. Suppression of lymphokine-activated killer induction by neutrophils.
Shau HY; Kim A
J Immunol; 1988 Dec; 141(12):4395-402. PubMed ID: 3264311
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of lymphokine-activated killer- and natural killer-mediated cytotoxicities by neutrophils.
Shau HY; Golub SH
J Immunol; 1989 Aug; 143(3):1066-72. PubMed ID: 2787346
[TBL] [Abstract][Full Text] [Related]
3. Suppression of lymphokine-activated killer (LAK) cell function by neutrophil polymorphonuclear leukocytes.
Ottonello L; Dallegri F; Dapino P; Patrone F; Sacchetti C
J Clin Lab Immunol; 1991 Jan; 34(1):37-40. PubMed ID: 1667940
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effects of alloimmune T cells on the generation of cytolytic responses of lymphokine-activated killer cells.
Sugarbaker PH; Matthews W; Steller EP; Eggermont AM
J Biol Response Mod; 1987 Aug; 6(4):430-45. PubMed ID: 3498012
[TBL] [Abstract][Full Text] [Related]
5. Generation of lymphokine-activated killer cells does not require DNA synthesis.
Malkovský M; Jíra M; Madar J; Malkovska V; Loveland B; Asherson GL
Immunology; 1987 Mar; 60(3):471-3. PubMed ID: 3494672
[TBL] [Abstract][Full Text] [Related]
6. Characteristics and mechanism of neutrophil-mediated cytostasis induced by tumor necrosis factor.
Shau H
J Immunol; 1988 Jul; 141(1):234-40. PubMed ID: 3379304
[TBL] [Abstract][Full Text] [Related]
7. Regulation of natural killer function by nonlymphoid cells.
Shau H; Roth MD; Golub SH
Nat Immun; 1993; 12(4-5):235-49. PubMed ID: 8257829
[TBL] [Abstract][Full Text] [Related]
8. Cancer-associated SCM-recognition, immunedefense suppression, and serine protease protection peptide. Part II. Immunedefense suppressive effects of the CRISPPs peptide.
Cercek L; Cercek B
Cancer Detect Prev; 1993; 17(3):433-45. PubMed ID: 7691405
[TBL] [Abstract][Full Text] [Related]
9. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG
Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor-beta 1 (TGF-beta 1) and recombinant human tumor necrosis factor-alpha reciprocally regulate the generation of lymphokine-activated killer cell activity. Comparison between natural porcine platelet-derived TGF-beta 1 and TGF-beta 2, and recombinant human TGF-beta 1.
Espevik T; Figari IS; Ranges GE; Palladino MA
J Immunol; 1988 Apr; 140(7):2312-6. PubMed ID: 3280680
[TBL] [Abstract][Full Text] [Related]
11. Activated alpha 2-macroglobulin reverses the immunosuppressive activity in human breast cancer cell-conditioned medium by selectively neutralizing transforming growth factor-beta in the presence of interleukin-2.
Harthun NL; Weaver AM; Brinckerhoff LH; Deacon DH; Gonias SL; Slingluff CL
J Immunother; 1998 Mar; 21(2):85-94. PubMed ID: 9551359
[TBL] [Abstract][Full Text] [Related]
12. IL-4 inhibits IL-2 induction of LAK cytotoxicity in lymphocytes from a variety of lymphoid tissues.
Colquhoun SD; Economou JS; Shau H; Golub SH
J Surg Res; 1993 Nov; 55(5):486-92. PubMed ID: 8231167
[TBL] [Abstract][Full Text] [Related]
13. Characterization of an oxidation-resistant tumor cell line and its sensitivity to immune response and chemotherapy.
Sauri H; Kim AT; Shau H
J Surg Res; 1995 May; 58(5):526-35. PubMed ID: 7745966
[TBL] [Abstract][Full Text] [Related]
14. Lymphokine-activated killer (LAK) cell generation from peripheral blood stem cells by in vitro incubation with low-dose interleukin-2 plus granulocyte-macrophage colony-stimulating factor.
Herrera C; García-Pérez MJ; Ramirez R; Martín C; Alvarez MA; Martinez F; Gómez P; García-Castellano JM; Torres A
Bone Marrow Transplant; 1997 Mar; 19(6):545-51. PubMed ID: 9085733
[TBL] [Abstract][Full Text] [Related]
15. The differential effects of polymorphonuclear leukocyte secretion on human natural killer cell activity.
Lala A; Lindemann RA; Miyasaki KT
Oral Microbiol Immunol; 1992 Apr; 7(2):89-95. PubMed ID: 1528637
[TBL] [Abstract][Full Text] [Related]
16. Membrane-associated lymphotoxin-expressing lymphokine-activated killer cells up-regulate intercellular adhesion molecule-1 expression on target tumor cells in vitro.
Kimura K; Abe Y; Horiuchi A; Miyake M; Kimura S
Cell Immunol; 1995 Aug; 164(1):119-25. PubMed ID: 7634343
[TBL] [Abstract][Full Text] [Related]
17. Expression and function of TNF-related apoptosis-inducing ligand on murine activated NK cells.
Kayagaki N; Yamaguchi N; Nakayama M; Takeda K; Akiba H; Tsutsui H; Okamura H; Nakanishi K; Okumura K; Yagita H
J Immunol; 1999 Aug; 163(4):1906-13. PubMed ID: 10438925
[TBL] [Abstract][Full Text] [Related]
18. Interleukin 2 induces human acute lymphocytic leukemia cells to manifest lymphokine-activated-killer (LAK) cytotoxicity.
Kaufmann Y; Levanon M; Davidsohn J; Ramot B
J Immunol; 1987 Aug; 139(3):977-82. PubMed ID: 3496395
[TBL] [Abstract][Full Text] [Related]
19. Platelet-activating factor synthesized by IL-12-stimulated polymorphonuclear neutrophils and NK cells mediates chemotaxis.
Bussolati B; Mariano F; Cignetti A; Guarini A; Cambi V; Foà R; Piccoli G; Camussi G
J Immunol; 1998 Aug; 161(3):1493-500. PubMed ID: 9686616
[TBL] [Abstract][Full Text] [Related]
20. Regulation of NK cell function by human granulocyte arginase.
Oberlies J; Watzl C; Giese T; Luckner C; Kropf P; Müller I; Ho AD; Munder M
J Immunol; 2009 May; 182(9):5259-67. PubMed ID: 19380772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
